InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Chin Richard, Chairman & CEO. Director active across 1 company, notably Kindred Biosciences, Inc.. Cumulatively, 8 filings have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €1.2m. History available since 16 June 2021. The latest transaction was filed on 27 August 2021 (Disposition). Regulator: SEC (Form 4). The full history is free.
Declarations8 total
1,709,271 shares@ US$9.2547.8% of flowCommon StockSEC:0001250853-21-000092
1,709,271 shares@ US$9.2547.8% of flowCommon StockSEC:0001250853-21-000092:0
320,000 shares0Common StockSEC:0001250853-21-000081:0
320,000 shares0Common StockSEC:0001250853-21-000081
40,000 shares@ US$9.1771.1% of flowCommon StockSEC:0001250853-21-000071:0
40,000 shares@ US$9.1771.1% of flowCommon StockSEC:0001250853-21-000071
40,000 shares@ US$9.18171.1% of flowCommon StockSEC:0001250853-21-000066
40,000 shares@ US$9.18171.1% of flowCommon StockSEC:0001250853-21-000066:0
8 of 8 declarations
About Chin Richard
Richard Chin is the Chief Executive Officer of Kindred Biosciences, Inc., a biotechnology company dedicated to improving animal health. In this role, he oversees the operations and strategy of the company. His expertise in biotechnology is essential for the success of Kindred Biosciences, Inc.
